Stratis Group
Stratis Group is a Florida-based healthcare consulting firm providing commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program services to pharmaceutical manufacturers, biotechnology companies, and physician networks. It was acquired by Nexus Health in March 2026.
- Company typePrivate
- Founded-
- HeadquartersPalm Beach Gardens, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Stratis Group does
Stratis Group is a US-based consulting firm specializing in primary research, analytics, and strategic advisory services for the pharmaceutical, biotechnology, and academic industries. Headquartered in Palm Beach Gardens, Florida, the company delivers a portfolio of five core service offerings: commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program design. Its work targets enterprise clients — primarily pharmaceutical manufacturers, biotechnology companies, and physician networks — that face increasing complexity around drug pricing, payer coverage, and patient access as therapies move toward commercialization.
The company's "technology" is positioned as advanced analytics and forecasting capabilities, applied through a consultative engagement model rather than as a unified software platform. Its value proposition rests on domain specialization in life sciences market access and the integration of analytics with patient support program design, reimbursement strategy, and commercialization planning. Pricing is not publicly disclosed; services are understood to be delivered on a project-by-project or retainer basis typical of professional services firms.
In March 2026, Stratis Group was acquired by Nexus Health, part of The Lockwood Group, which is owned by Ares Management Corporation. The transaction combined Stratis's analytics, forecasting, and patient support capabilities with Nexus Health's medical affairs, oncology education, and access strategy offerings, with Clearsight Advisors acting as financial advisor. Post-acquisition, Stratis operates as a subsidiary within a PE-backed healthcare consulting platform.
Stratis Group firmographics
Firmographics- Name
- Stratis Group
- Legal name
- Stratis Group
- Website
- https://stratisgrp.com
- Company type
- Private
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- Stratis Group is a Florida-based healthcare consulting firm providing commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program services to pharmaceutical manufacturers, biotechnology companies, and physician networks. It was acquired by Nexus Health in March 2026.
- Ownership category
- akta.pro rank
Where Stratis Group is headquartered
LocationHeadquarters
- HQ city
- Palm Beach Gardens
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Stratis Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Strategic Consulting Services: Revenue generated from providing commercialization strategy, market access optimization, and analytics consulting services to pharmaceutical, biotechnology, and physician network clients
Go-to-market motion1 record
Distribution channels1 record
Stratis Group product offering
Product offeringCore offering
Stratis Group is a healthcare and life sciences consulting firm that delivers commercialization strategy, market access, advanced analytics, forecasting, and patient support program advisory services to pharmaceutical manufacturers, biotechnology companies, and physician networks. Engagements focus on helping clients navigate drug pricing, coverage, and patient access complexity as therapies move toward commercialization.
Product overview
Stratis Group is a healthcare consulting firm offering a portfolio of advisory services for the life sciences industry. The company provides commercialization strategy, market access optimization, advanced analytics, forecasting, and patient support program services to pharmaceutical, biotechnology, and physician network clients. Rather than a unified software platform, Stratis Group delivers these as discrete consulting service offerings focused on helping clients navigate drug pricing complexity, coverage decisions, and patient access challenges during therapy commercialization.
Differentiator
Problem solved
Functional benefit
Products and services
- Commercialization Strategy Services Consulting services helping pharmaceutical, biotechnology, and physician network clients develop and execute go-to-market strategies for their products.
- Market Access Services Advisory services focused on optimizing market access, reimbursement strategy, and payer negotiations for life sciences products.
- Advanced Analytics Data analytics offerings providing insights for pharmaceutical commercialization, forecasting, and market opportunity assessment.
- Patient Support Programs Program design and optimization services for patient support initiatives to improve therapy access and adherence.
- Forecasting Services Market forecasting and predictive analytics services to support commercial planning and investment decisions.
Quantifiable outcome
- Enhanced capabilities in healthcare services and market access through strategic acquisition
Companies that use Stratis Group
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Stratis Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Stratis Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- The Lockwood GroupcoreThe Lockwood Group, owned by Ares Management Corporation, acquired Stratis Group through its Nexus Health subsidiary as part of a broader growth strategy to expand its commercialization and market access platform across the life sciences industry.
- Nexus HealthcoreNexus Health, a strategic consulting and market access firm and part of The Lockwood Group, acquired Stratis Group. The acquisition combines Stratis Group's expertise in advanced analytics, forecasting, patient support programs, and market access optimization with Nexus Health's existing capabilities in medical affairs, oncology education, and access strategy.
Scale indicators2 records
Recent moves3 records
Expansion highlights3 records
Stratis Group competitors and assessment
Company assessmentDirect peers
- Apex Market Access: Boutique consultancy focused on market access strategy and payer engagement for pharma and biotech. Comparable to Stratis in service scope and target client profile.
- ZS Associates: Specialist consultancy focused on pharma sales, marketing, and market access analytics. Directly comparable to Stratis in offering advanced analytics and commercialization strategy for pharmaceutical manufacturers.
- Beghou Consulting: Boutique life sciences consultancy serving pharma and biotech on commercialization, market access, and advanced analytics. Closest direct competitor to Stratis in size, service mix, and target customer profile.
- Precision Medicine Group: Specialized commercialization and market access services for biotech and pharma. Highly comparable to Stratis in patient support programs, market access strategy, and commercial analytics offerings.
- Evidera: Market access, health economics, and outcomes research consultancy serving biopharma. Overlaps with Stratis's reimbursement strategy, market access, and commercialization analytics services.
Broad incumbents
- IQVIA: Largest life sciences commercial and clinical services firm. Overlaps with Stratis in pharma market access, commercialization analytics, and forecasting, but operates at vastly greater scale across the full drug development lifecycle.
- Syneos Health: Large CRO with a commercial solutions practice covering market access, patient support, and commercialization strategy. Broader portfolio than Stratis but directly overlapping in pharma commercialization services.
- Deloitte (Life Sciences & Health Care): Big Four consultancy with a dedicated life sciences practice covering market access, commercial strategy, and analytics. Represents scaled-incumbent competition for boutique players like Stratis.
- McKinsey (Pharma & Medical Products): Global strategy firm with a large pharma practice covering market access, commercial excellence, and analytics. Represents top-tier competition for Stratis's commercialization and pricing strategy engagements.
Emerging players
- LSC Life Sciences: Life sciences consulting and analytics firm serving pharma and biotech clients. Comparable in offering strategy and analytics services to specialty pharma clients.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
Stratis Group social profiles
Digital presenceStratis Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Stratis Group leadership team
Management profileNumber of profiles
Stratis Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Stratis Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Stratis Group
What does Stratis Group do?
Stratis Group is a healthcare and life sciences consulting firm that delivers commercialization strategy, market access, advanced analytics, forecasting, and patient support program advisory services to pharmaceutical manufacturers, biotechnology companies, and physician networks. Engagements focus on helping clients navigate drug pricing, coverage, and patient access complexity as therapies move toward commercialization.
Is Stratis Group a public or private company?
Stratis Group is a private company. It is classified as private equity controlled and is currently acquired.
When was Stratis Group founded?
Stratis Group was founded in -1. It employs 51 to 100 people.
Where is Stratis Group based?
Stratis Group is headquartered in Palm Beach Gardens, United States, in the North America region.
How does Stratis Group make money?
One revenue line is on record: strategic Consulting Services.
Who are Stratis Group's main competitors?
Direct peers on record are Apex Market Access, ZS Associates, Beghou Consulting, Precision Medicine Group and Evidera. Broad incumbents are IQVIA, Syneos Health, Deloitte (Life Sciences & Health Care) and McKinsey (Pharma & Medical Products). LSC Life Sciences is listed as an emerging player.
Does Stratis Group have an API?
No public API is recorded for Stratis Group.